Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 5c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of ($0.12), $0.05 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.07 million versus the consensus estimate of $8.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• HSBC Downgrades Iflytek Co Ltd (002230:CH) to Hold